Latisse and Body Dysmorphic Disorder (BDD)

In late 2008, the drug Lumigan, originally developed to treat glaucoma, was approved by the Food and Drug Administration (FDA) to be prescribed as an eyelash enhancer.  It seems that one of the side effects of the glaucoma drug, now called Latisse when marketed for eyelash enhancement, is eyelash growth.  According to a recent article in the Los Angeles Times, Latisse is being prescribed by dermatologists, plastic surgeons, and day spa physicians to women who want to increase the length and fullness of their lashes.

Is this a good thing?  One of the most common issues we see in our clients with Body Dysmorphic Disorder (BDD) is excessive focus on the appearance of their eyes, including their eyelashes.  Latisse plays right into this common BDD concern. › Continue reading

Tags: Allergan, Body Dysmorphic Disorder (BDD), Body Image, Cognitive-Behavioral Therapy (CBT), Cosmetic Surgery, Dermatology, Eyelashes, Health, Latisse

OCD & Anxiety: The Year 2009 in Review

Obsessive Compulsive Disorder (OCD) and anxiety were in the news throughout 2009.  Some news was good, some bad, and some flat-out ugly.  Here are our votes for the top stories of the year related to OCD, Social Anxiety, Body Dysmorphic Disorder (BDD), Trichotillomania, Phobias, and Cognitive Behavioral Therapy (CBT): › Continue reading

Tags: Anxiety, Body Dysmorphic Disorder (BDD), Cognitive-Behavioral Therapy (CBT), H1N1, Health, Howie Mandel, Latisse, National Health Care Bill, Obsessive-Compulsive Disorder (OCD), Phobias, Social Anxiety / Social Phobia, Swine Flu, Trichotillomania, Zack Greinke